Article info

Download PDFPDF
P05 Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study

Authors

Citation

Kolberg H, Colleoni M, Savva Demetriou G, et al
P05 Cardiac safety of the trastuzumab biosimilar ABP 980 in women with HER2-positive early breast cancer in the LILAC study

Publication history

  • First published November 1, 2019.
Online issue publication 
August 11, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.